In 2003, MTX was used less, whereas other nonbiologic DMARDs, including salazosulfapyridine (SASP), bucillamine (BUC) and gold sodium thiomalate, were used more frequently. However, after the ...

Int J Clin Rheumatol. 2012;7(2):179-189. In another study of 23,810 patients with RA from Quebec (Canada) over the period 1980–2003, [70] hematologic malignant neoplasms developed in 619 ...